Skip to main content

Table 4 Multivariate analysis of risk factors of overall survival and progression-free survival

From: Prognostic value of baseline total metabolic tumour volume of 18F-FDG PET/CT imaging in patients with angioimmunoblastic T-cell lymphoma

 

Characteristics

HR (95% CI)

p

Characteristics

HR (95% CI)

p

OS

TMTV > 514.6 cm3

2.586 (1.174–5.696)

0.018

TLG > 2141.0

 

Low albumin

Low albumin

 

Low PLT

Low PLT

 

BMB positive

BMB positive

 

ECOG-PS > 1

2.826 (1.285–6.216)

0.010

ECOG-PS > 1

3.652 (1.714–7.781)

0.001

 

B symptoms

B symptoms

PFS

TMTV > 514.6 cm3

2.333 (1.205–4.516)

0.012

TLG > 2141.0a

 

Low PLT

2.425 (1.283–4.584)

0.006

Low PLT

2.053 (1.029–4.095)

0.041

 

BMB positive

BMB positive

 

Age > 60

Age > 60

 

ECOG-PS > 1

ECOG-PS > 1

2.107 (0.976–4.547)

0.058

 

B symptoms

B symptoms

  1. PFS, progression-free survival; OS, overall survival; HR, hazard ratio; CI, confidence interval; ECOG-PS, Eastern Cooperative Oncology Group Performance Status; PLT, platelet; BMB, bone marrow biopsy; TMTV, total metabolic tumour volume; TLG, total lesion glycolysis
  2. aTMTV and TLG were separately incorporated into multivariate survival analysis due to the correlation between TMTV and TLG